B. Stewart and C. P. Wild, World cancer report, 2014.

P. Senesse, P. Bachmann, and R. J. Bensadoun, Clinical nutrition guidelines of the French Speaking Society of Clinical Nutrition and Metabolism (SFNEP): summary of recommendations for adults undergoing non-surgical anticancer treatment, Dig Liver Dis, 2014.

G. De-pergola and F. Silvestris, Obesity as a major risk factor for cancer, J Obes, p.291546, 2013.

C. Arce-salinas, J. L. Aguilar-ponce, and C. Villarreal-garza, Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients, Breast Cancer Res Treat, vol.146, pp.183-188, 2014.

V. C. Herlevic, R. Mowad, and J. K. Miller, Breast cancer outcomes in a population with high prevalence of obesity, J Surg Res, vol.198, pp.371-376, 2015.

A. Von-drygalski, T. B. Tran, and K. Messer, Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support, Int J Breast Cancer, pp.1-8, 2011.

D. Chan, A. R. Vieira, and D. Aune, Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies, Ann Oncol, vol.25, pp.1901-1914, 2014.

R. S. Cecchini, S. M. Swain, and J. P. Costantino, Body mass index at diagnosis and breast cancer survival prognosis in clinical trial populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38, Cancer Epidemiol Prev Biomark, vol.25, pp.51-59, 2016.

A. Gennari, D. Amadori, and E. Scarpi, Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy, Breast Cancer Res Treat, vol.159, pp.79-86, 2016.

C. Prado, J. R. Lieffers, and L. J. Mccargar, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol, vol.9, pp.629-635, 2008.

N. Mitsiopoulos, R. N. Baumgartner, and S. B. Heymsfield, Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography, J Appl Physiol Bethesda Md, vol.85, pp.115-122, 1998.

I. J. Rutten, D. P. Dijk, and R. F. Kruitwagen, Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients, J Cachex Sarcopenia Muscle, vol.7, pp.458-466, 2016.

P. Anandavadivelan, T. B. Brismar, and M. Nilsson, Sarcopenic obesity: a probable risk factor for dose limiting toxicity during neoadjuvant chemotherapy in oesophageal cancer patients, Clin Nutr, vol.35, 2016.

S. Antoun, I. Borget, and E. Lanoy, Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer, 2013.

, Curr Opin Support Palliat Care, vol.7, pp.383-389

T. M. Lodewick, T. Van-nijnatten, and R. M. Van-dam, Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases, HPB, vol.17, pp.438-446, 2015.

L. Martin, L. Birdsell, and N. Macdonald, Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J Clin Oncol Off J Am Soc Clin Oncol, vol.31, pp.1539-1547, 2013.

S. S. Shachar, G. R. Williams, H. B. Muss, and T. F. Nishijima, Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review, Eur J Cancer Oxf Engl, vol.57, pp.58-67, 2016.

E. D. Fabbro, H. Parsons, and C. L. Warneke, The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer, Oncologist, vol.17, pp.1240-1245, 2012.

A. Villaseñor, R. Ballard-barbash, and K. Baumgartner, Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study, J Cancer Surviv, vol.6, pp.398-406, 2012.

A. L. Wong, K. Y. Seng, and E. M. Ong, Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients, Breast Cancer Res Treat, vol.144, pp.143-152, 2014.

T. Iwase, T. Sangai, and T. Nagashima, Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients, Cancer Med, vol.5, pp.41-48, 2016.

S. Antoun, A. Bayar, and I. E. , High subcutaneous adipose tissue predicts the prognosis in metastatic castrationresistant prostate cancer patients in post chemotherapy setting, 2015.

, Eur J Cancer Oxf Engl, vol.51, pp.2570-2577

B. Cutuli, S. Giard-lefevre, and A. M. , Cancer du sein infiltrant non métastatique-questions d'actualités (synthèse) 82, 2012.

W. Shen, M. Punyanitya, and Z. Wang, Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image, J Appl Physiol Bethesda Md, vol.97, pp.2333-2338, 2004.

S. S. Shachar, A. M. Deal, and M. Weinberg, Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane based chemotherapy, Clin Cancer Res Clincanres, 2016.

B. Guiu, J. M. Petit, and F. Bonnetain, Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer, Gut, vol.59, pp.341-347, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00476649

H. Moon, Y. Ju, and C. Jeong, Visceral obesity may affect oncologic outcome in patients with colorectal cancer, Ann Surg Oncol, vol.15, pp.1918-1922, 2008.

C. Yip, C. Dinkel, and A. Mahajan, Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome, Insights Imaging, vol.6, pp.489-497, 2015.

D. Sottier, J. Petit, and S. Guiu, Quantification of the visceral and subcutaneous fat by computed tomography: interobserver correlation of a single slice technique, Diagn Interv Imaging, vol.94, pp.879-884, 2013.

A. J. Cruz-jentoft, J. P. Baeyens, and J. M. Bauer, Sarcopenia: European consensus on definition and diagnosis report of the European working group on sarcopenia in older people, Age Ageing, vol.39, pp.412-423, 2010.

R. Fielding, D. Kirn, and A. Koochek, 5: impact of a structured physical activity program and nutritional supplementation on regional body composition: results from the Vitality, Independence, and Vigor in the Elderly 2 Study (VIVE2), Clin Nutr, vol.35, pp.30294-30295, 2016.

I. Janssen, S. B. Heymsfield, and R. Ross, Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability, J Am Geriatr Soc, vol.50, pp.889-896, 2002.

D. Van-dijk, M. Bakens, and M. Coolsen, Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer, J Cachexia Sarcopenia Muscle, 2016.

T. Y. Kim, M. Y. Kim, and J. H. Sohn, Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites, J Korean Med Sci, vol.29, pp.1253-1259, 2014.

Y. Matsuzawa, New criteria for Bobesity disease^ in Japan: the Examination Committee of Criteria for BObesity Disease^ in Japan, Japan Society for the Study of Obesity, Circ J Off J Jpn Circ Soc, vol.66, pp.987-992, 2002.

J. Xiao, V. C. Mazurak, and T. A. Olobatuyi, Visceral adiposity and cancer survival: a review of imaging studies, Eur J Cancer Care (Engl, 2016.